Diagnosis, prognosis and mechanism of sarcopenia in renal transplant recipients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300078328

Enrollment

Unknown

Registered

2023-12-05

Start date

2023-12-05

Completion date

Unknown

Last updated

2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal transplantion

Interventions

sarcopenia and nonsarcopenia renal transplant recipients:none

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients underwent renal transplantation in the Department of Urology, West China Hospital of Sichuan University; (2)over 18 years old; (3) patients voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) patients with neuromuscular diseases, such as myasthenia gravis, muscular dystrophy, myositis, etc; (2) the patient cannot stand alone or maintain a standing posture; (3) the BIA test could not be performed due to the implantation of electronic devices or metal or amputation.

Design outcomes

Primary

Measure	Time frame
Survival;Renal allograft survival;	—

Secondary

Measure	Time frame
Delayed recovery of renal allograft function;Acute rejection reaction;Infection;Re-admission;	—

Countries

China

Contacts

Public ContactYu Fan

West China Hospital, Sichuan University, Chengdu, Sichuan, China

kidney_fy@163.com+86 182 2406 8823

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026